Phase 2 clinical trial for pneumococcal conjugate vaccine
Latest Information Update: 07 Apr 2020
At a glance
- Drugs SP-0202 (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
Most Recent Events
- 07 Apr 2020 New trial record
- 30 Mar 2020 According to a SK Bioscience media release, the company announced that an IND amendment for a phase 2 clinical trial with the Next-Generations PCV was filed last month in the United States with plans for the trial to be initiated following regulatory review.